Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib. (Q52927066)
Jump to navigation
Jump to search
scientific article published on 4 January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib. |
scientific article published on 4 January 2007 |
Statements
Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib. (English)
Marion Subklewe
Kathrin Sebelin-Wulf
Carola Beier
Andreas Lietz
Stephan Mathas
Bernd Dörken
Antonio Pezzutto
4 January 2007
68
3
147-155